Search research articles
Contact Us
Filters
Showing results (121-130 of 513) with videos related to
Page
of 52
Sort By:
European Journal of Radiology Open
|
May 27, 2021
Pleomorphic carcinoma of the lung: Prognostic models of semantic, radiomics and combined features from CT and PET/CT in 85 patients
Chohee Kim, Hwan-Ho Cho, Joon Young Choi, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
October 15, 2024
Comprehensive metabolomic analysis identifies key biomarkers and modulators of immunotherapy response in NSCLC patients
Se-Hoon Lee, Sujeong Kim, Jueun Lee, et al.
Genome Medicine
|
December 24, 2023
Systematic analysis of Mendelian disease-associated gene variants reveals new classes of cancer-predisposing genes
Seulki Song, Youngil Koh, Seokhyeon Kim, et al.
Translational Oncology
|
August 28, 2015
Detection of a Distinctive Genomic Signature in Rhabdoid Glioblastoma, A Rare Disease Entity Identified by Whole Exome Sequencing and Whole Transcriptome Sequencing
Youngil Koh, Inho Park, Chung-Hyun Sun, et al.
Cancer Research and Treatment
|
July 19, 2014
Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
The Korean Journal of Internal Medicine
|
March 29, 2016
Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
Sehhoon Park, Seongyeol Park, Se-Hoon Lee, et al.
Cancer Research and Treatment
|
October 25, 2013
How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
Cancer Chemotherapy and Pharmacology
|
September 7, 2014
Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program
Jae-Lyun Lee, Se Hoon Park, Su-Jin Koh, et al.
Thoracic Cancer
|
April 5, 2016
Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors
Sung Hoon Sim, Seung-Hoon Beom, Yong-Oon Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 24, 2012
EGFR mutations as a predictive marker of cytotoxic chemotherapy
Jin Hyun Park, Se-Hoon Lee, Bhumsuk Keam, et al.
Page
of 52
Search research articles
Search
Showing results (121-130 of 513) with videos related to
Sort By:
Page
of 52
European Journal of Radiology Open
|
May 27, 2021
Pleomorphic carcinoma of the lung: Prognostic models of semantic, radiomics and combined features from CT and PET/CT in 85 patients
Chohee Kim, Hwan-Ho Cho, Joon Young Choi, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
October 15, 2024
Comprehensive metabolomic analysis identifies key biomarkers and modulators of immunotherapy response in NSCLC patients
Se-Hoon Lee, Sujeong Kim, Jueun Lee, et al.
Genome Medicine
|
December 24, 2023
Systematic analysis of Mendelian disease-associated gene variants reveals new classes of cancer-predisposing genes
Seulki Song, Youngil Koh, Seokhyeon Kim, et al.
Translational Oncology
|
August 28, 2015
Detection of a Distinctive Genomic Signature in Rhabdoid Glioblastoma, A Rare Disease Entity Identified by Whole Exome Sequencing and Whole Transcriptome Sequencing
Youngil Koh, Inho Park, Chung-Hyun Sun, et al.
Cancer Research and Treatment
|
July 19, 2014
Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
The Korean Journal of Internal Medicine
|
March 29, 2016
Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
Sehhoon Park, Seongyeol Park, Se-Hoon Lee, et al.
Cancer Research and Treatment
|
October 25, 2013
How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
Cancer Chemotherapy and Pharmacology
|
September 7, 2014
Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program
Jae-Lyun Lee, Se Hoon Park, Su-Jin Koh, et al.
Thoracic Cancer
|
April 5, 2016
Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors
Sung Hoon Sim, Seung-Hoon Beom, Yong-Oon Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 24, 2012
EGFR mutations as a predictive marker of cytotoxic chemotherapy
Jin Hyun Park, Se-Hoon Lee, Bhumsuk Keam, et al.
Page
of 52